dipyridamole has been researched along with Eosinophilia in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spry, CJ | 1 |
| Davies, J | 1 |
| Tai, PC | 1 |
| Olsen, EG | 1 |
| Oakley, CM | 1 |
| Goodwin, JF | 1 |
1 other study available for dipyridamole and Eosinophilia
| Article | Year |
|---|---|
Clinical features of fifteen patients with the hypereosinophilic syndrome.
Topics: Adolescent; Adult; Aged; Anticoagulants; Dipyridamole; Eosinophilia; Eosinophils; Female; Humans; Le | 1983 |